Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neuropharmacology ; 48(8): 1086-96, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15910885

RESUMO

Exogenously administered cannabinoids are neuroprotective in several different cellular and animal models. In the current study, two cannabinoid CB1 receptor ligands (WIN 55,212-2, CP 55,940) markedly reduced hippocampal cell death, in a time-dependent manner, in cultured neurons subjected to high levels of NMDA (15 microM). WIN 55,212-2 was also shown to inhibit the NMDA-induced increase in intracellular calcium concentration ([Ca2+](i)) indicated by FURA-2 fluorescence imaging in the same cultured neurons. Changes in [Ca2+](i) occurred with similar concentrations (25-100 nM) and in the same time-dependent manner (pre-exposure 1-15 min) as CB1 receptor mediated neuroprotective actions. Both effects were blocked by the CB1 receptor antagonist SR141716A. An underlying mechanism was indicated by the fact that (1) the NMDA-induced increase in [Ca2+](i) was inhibited by ryanodine, implicating a ryanodine receptor (RyR) coupled intracellular calcium channel, and (2) the cannabinoid influence involved a reduction in cAMP cAMP-dependent protein kinase (PKA) dependent phosphorylation of the same RyR levels that regulate channel. Moreover the time course of CB1 receptor mediated inhibition of PKA phosphorylation was directly related to effective pre-exposure intervals for cannabinoid neuroprotection. Control studies ruled out the involvement of inositol-trisphosphate (IP3) pathways, enhanced calcium reuptake and voltage sensitive calcium channels in the neuroprotective process. The results suggest that cannabinoids prevent cell death by initiating a time and dose dependent inhibition of adenylyl cyclase, that outlasts direct action at the CB1 receptor and is capable of reducing [Ca2+](i) via a cAMP/PKA-dependent process during the neurotoxic event.


Assuntos
Cálcio/metabolismo , Fármacos Neuroprotetores/farmacologia , Receptor CB1 de Canabinoide/agonistas , Receptor CB1 de Canabinoide/antagonistas & inibidores , Rianodina/farmacologia , Animais , Benzoxazinas/farmacologia , Técnicas de Cultura de Células , Morte Celular/efeitos dos fármacos , AMP Cíclico/análogos & derivados , AMP Cíclico/farmacologia , Proteínas Quinases Dependentes de AMP Cíclico/antagonistas & inibidores , Cicloexanóis/farmacologia , Dantroleno/farmacologia , Interações Medicamentosas , Estrenos/farmacologia , Feto , Hipocampo/efeitos dos fármacos , Hipocampo/metabolismo , Compostos Macrocíclicos/farmacologia , Morfolinas/farmacologia , N-Metilaspartato/farmacologia , Naftalenos/farmacologia , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Ácido Okadáico/farmacologia , Oxazóis/farmacologia , Piperidinas/farmacologia , Pirazóis/farmacologia , Pirrolidinonas/farmacologia , Ratos , Ratos Endogâmicos , Rimonabanto , Tionucleotídeos/farmacologia
2.
J Neurophysiol ; 90(1): 55-64, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12649318

RESUMO

A number of recent studies have demonstrated that a well-known form of short-term plasticity at hippocampal GABAergic synapses, called depolarization-induced suppression of inhibition (DSI), is in fact mediated by the retrograde actions of endocannabinoids released in response to depolarization of the postsynaptic cells. These studies suggest that endogenous cannabinoids may play an important role in regulating inhibitory tone in the mammalian CNS. Despite the widespread interest and potential physiological importance of DSI, many questions regarding the physiological relevance of DSI remain. To that end, this study set out to define the specific limiting conditions that could elicit DSI at GABAergic synapses in CA1 hippocampal pyramidal neurons and to determine if DSI could be elicited with pulse trains that mimic hippocampal cell-firing patterns that occur in vivo. Whole cell recordings from hippocampal neurons under voltage-clamp configuration were made in rat hippocampal slices. Spontaneous and evoked gamma-aminobutyric acid-A (GABAA) receptor-mediated inhibitory postsynaptic currents (sIPSCs and eIPSCs, respectively) were recorded prior to and following depolarization of CA1 hippocampal pyramidal cells. Depolarizing voltage pulses were shaped to evoke currents in QX-314-treated cells similar to those accompanying single spontaneous voltage-clamped action potentials recorded from the soma. Attempts were made to elicit DSI with trains of these pulses that mimicked hippocampal cell firing patterns in vivo, for instance, when animals traverse place fields or are performing a short-term memory task. DSI could not be elicited by such pulse trains or by a number of other combinations of behaviorally specific firing parameters. The minimum duration of depolarization necessary to elicit DSI in hippocampal neurons determined by paired-pulse manipulation was 50 -75 ms at a critical interval of 20 -30 ms between pulse pairs. Under the conditions tested, the normal firing patterns of hippocampal neurons that occur in vivo do not appear to elicit DSI.


Assuntos
Canabinoides , Hipocampo/fisiologia , Lidocaína/análogos & derivados , Inibição Neural , Células Piramidais/fisiologia , Receptores de Droga/fisiologia , Receptores de GABA-A/fisiologia , Ácido gama-Aminobutírico , Potenciais de Ação/efeitos dos fármacos , Animais , Benzoxazinas , Bloqueadores dos Canais de Cálcio/farmacologia , Moduladores de Receptores de Canabinoides , Canabinoides/administração & dosagem , Colforsina/farmacologia , Estimulação Elétrica , Ativadores de Enzimas/farmacologia , Inibidores Enzimáticos/farmacologia , Hipocampo/efeitos dos fármacos , Interneurônios/fisiologia , Lidocaína/farmacologia , Masculino , Toxinas Marinhas , Morfolinas/farmacologia , Naftalenos/farmacologia , Oxazóis/farmacologia , Técnicas de Patch-Clamp , Células Piramidais/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Receptores de Canabinoides , Receptores de Droga/agonistas , Receptores de Droga/antagonistas & inibidores , Bloqueadores dos Canais de Sódio/farmacologia , ômega-Conotoxina GVIA/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...